Sophia Genetics (FRA:90B) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:90B Sophia Genetics SA FRA:90B
54 GF Score
Price €6.60
GF Value €4.71
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Sophia Genetics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:90B
54GF Score
Sophia Genetics SA FRA:90B
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sophia Genetics (FRA:90B) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of €6.60 is trading 40.1% above its estimated GF Value™ of €4.71. GuruFocus considers Sophia Genetics to be Significantly Overvalued.

Key valuation signals for FRA:90B:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €4.71 vs. price of €6.60 (40.1% above fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the FRA:90B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges SOPH:USA90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
54GF Score

Get the complete analysis for FRA:90B

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.60
Price
€4.71
GF Value